Andrew Lyle

Bio:

Andrew Lyle is a pharmaceutical industry leader with 15 years of experience, including 8 years at AstraZeneca Oncology, where he launched 13 indications across 5 products spanning lung, endometrial/ovarian, gastric, and hematology tumor types - many of which achieved blockbuster status. He currently serves as Hematology Marketing Director at Genmab, bringing deep expertise in commercializing oncology products. Andrew has a proven track record of building omnichannel ecosystems and delivering robust customer experiences that drive product success in competitive therapeutic areas.